The Role of Fibroscan in Assessment of Liver Fibrosis in Patients With Diabetes Mellitus and Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)

被引：0
|
作者：
Menon, Raakhi [1 ]
Movva, Giri [1 ]
Garza, Devin [1 ]
Butt, Edward [1 ]
Zhang, Julia [1 ]
Khan, Kashif [1 ]
机构：
[1] Univ Texas Med Branch, Galveston, TX USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001036180.44221.bc
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1703
引用
收藏
页码：S1240 / S1240
页数：1
相关论文
共 50 条
  • [31] Clusters of metabolic dysfunction-associated steatotic liver disease for precision medicine MASLD
    Stefan, Norbert
    Targher, Giovanni
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2025, : 226 - 227
  • [32] Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?
    Kasprzak-Drozd, Kamila
    Nizinski, Przemyslaw
    Kasprzak, Paulina
    Kondracka, Adrianna
    Oniszczuk, Tomasz
    Rusinek, Agata
    Oniszczuk, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [33] METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IS ASSOCIATED WITH LIVER FIBROSIS IN HEPATITIS C
    Elgretli, Wesal
    Shengir, Mohamed
    Sasson, Solomon
    Agnihotram, V. Ramanakumar
    Ballesteros, Luz Esther Ramos
    Deschenes, Marc
    Wong, Philip
    Chen, Tianyan
    Kronfli, Nadine
    Keeshan, Alexa
    Tandon, Saniya
    Cooper, Curtis
    Sebastiani, Giada
    HEPATOLOGY, 2024, 80 : S382 - S383
  • [34] Gestational diabetes mellitus may predispose to metabolic dysfunction-associated steatotic liver disease
    Milionis, Charalampos
    Ilias, Ioannis
    Koukkou, Eftychia
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (05)
  • [35] Predictors of advanced liver fibrosis and the performance of fibrosis scores: lean compared to non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) patients
    Dabbah, Shoham
    Ben Yakov, Gil
    Kaufmann, Monika-Inda
    Cohen-Ezra, Oranit
    Likhter, Maria
    Davidov, Yana
    Ben Ari, Ziv
    MINERVA GASTROENTEROLOGY, 2024, 70 (03): : 322 - 331
  • [36] Predictors of Hepatic Fibrosis in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease
    de Abreu, Joana D'Arc Matos Franca
    Azulay, Rossana Sousa
    Rodrigues, Vandilson
    de Abreu, Sterffeson Lamare Lucena
    Tavares, Maria da Gloria
    Pinheiro, Flavia Coelho Mohana
    de Oliveira Neto, Clariano Pires
    Andrade, Caio
    Facundo, Alexandre
    Sa, Adriana Guimaraes
    Azevedo, Patricia Ribeiro
    de Almeida, Ana Gregoria Pereira
    Costa, Debora Camelo de Abreu
    Castro, Rogerio Soares
    Magalhaes, Marcelo
    Nascimento, Gilvan Cortes
    Faria, Manuel dos Santos
    Ferreira, Adalgisa de Souza Paiva
    BIOMEDICINES, 2024, 12 (11)
  • [37] The Role of Endoplasmic Reticulum in Lipotoxicity during Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Pathogenesis
    Venkatesan, Nanditha
    Doskey, Luke C.
    Malhi, Harmeet
    AMERICAN JOURNAL OF PATHOLOGY, 2023, 193 (12): : 1887 - 1899
  • [38] Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Zazueta, Alejandra
    Valenzuela-Perez, Lucia
    Ortiz-Lopez, Nicolas
    Pinto-Leon, Araceli
    Torres, Veronica
    Guinez, Danette
    Aliaga, Nicolas
    Merino, Pablo
    Sandoval, Alexandra
    Covarrubias, Natalia
    Perez de Arce, Edith
    Cattaneo, Maximo
    Urzua, Alvaro
    Roblero, Juan Pablo
    Poniachik, Jaime
    Gotteland, Martin
    Magne, Fabien
    Beltran, Caroll Jenny
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (08)
  • [39] Exploring Autoantibodies as Predictors of Severe Fibrosis or Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Response
    Faisal, Nabiha
    Minuk, Gerald
    CANADIAN LIVER JOURNAL, 2024, 7 (04): : 417 - 418
  • [40] PROGNOSTIC SIGNIFICANCE OF ELF TEST COMPARED TO LIVER BIOPSY IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Liguori, Antonio
    D'Ambrosio, Francesca
    Viceconti, Nicholas
    Termite, Fabrizio
    Petrucci, Lucrezia
    Galletti, Simone
    Cardinali, Sara
    Riccardi, Laura
    Pizzolante, Fabrizio
    De Matthaeis, Nicoletta
    Zocco, Maria Assunta
    Giustiniani, Maria Cristina
    Marrone, Giuseppe
    Biolato, Marco
    Rapaccini, Gian Ludovico
    Pompili, Maurizio
    Grieco, Antonio
    Urbani, Andrea
    Sanguinetti, Maurizio
    Gasbarrini, Antonio
    Miele, Luca
    HEPATOLOGY, 2024, 80 : S662 - S662
12345